Cargando…

Drivers of Irrational Use of Antibiotics in Europe

The unnecessary use of antibiotics and concomitant rapid growth of antibiotic resistance (ABR) is a widely acknowledged threat to global health, development, and sustainability. While the underlying cause of ABR is undoubtedly the overall volume of antibiotic use in general, irrational antibiotic us...

Descripción completa

Detalles Bibliográficos
Autores principales: Machowska, Anna, Stålsby Lundborg, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338985/
https://www.ncbi.nlm.nih.gov/pubmed/30583571
http://dx.doi.org/10.3390/ijerph16010027
_version_ 1783388531959267328
author Machowska, Anna
Stålsby Lundborg, Cecilia
author_facet Machowska, Anna
Stålsby Lundborg, Cecilia
author_sort Machowska, Anna
collection PubMed
description The unnecessary use of antibiotics and concomitant rapid growth of antibiotic resistance (ABR) is a widely acknowledged threat to global health, development, and sustainability. While the underlying cause of ABR is undoubtedly the overall volume of antibiotic use in general, irrational antibiotic use, which is influenced by several interrelated factors, is a major contributory factor. Here, we aimed to present and describe selected main drivers of irrational use of antibiotics in Europe. We performed a broad search of the current literature in databases such as PubMed, Google Scholar, Cochrane, as well as various institutional websites (World Health Organization, European Observatory, European Commission) to provide a new perspective on selected drivers of irrational antibiotic use in Europe. We also searched for relevant literature using snowballing, i.e., using reference lists of papers to identify additional papers. In this narrative review, we present that major factors among the general public driving antibiotic resistance are lack of public knowledge and awareness, access to antibiotics without prescription and leftover antibiotics, and knowledge attitude and perception of prescribers and dispensers, inadequate medical training, pharmaceutical promotion, lack of rapid and sufficient diagnostic tests, and patient–doctor interaction as major factors among healthcare providers. We further discuss initiatives that, if taken and implemented, can have an impact on and improve the current situation in Europe.
format Online
Article
Text
id pubmed-6338985
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63389852019-01-23 Drivers of Irrational Use of Antibiotics in Europe Machowska, Anna Stålsby Lundborg, Cecilia Int J Environ Res Public Health Review The unnecessary use of antibiotics and concomitant rapid growth of antibiotic resistance (ABR) is a widely acknowledged threat to global health, development, and sustainability. While the underlying cause of ABR is undoubtedly the overall volume of antibiotic use in general, irrational antibiotic use, which is influenced by several interrelated factors, is a major contributory factor. Here, we aimed to present and describe selected main drivers of irrational use of antibiotics in Europe. We performed a broad search of the current literature in databases such as PubMed, Google Scholar, Cochrane, as well as various institutional websites (World Health Organization, European Observatory, European Commission) to provide a new perspective on selected drivers of irrational antibiotic use in Europe. We also searched for relevant literature using snowballing, i.e., using reference lists of papers to identify additional papers. In this narrative review, we present that major factors among the general public driving antibiotic resistance are lack of public knowledge and awareness, access to antibiotics without prescription and leftover antibiotics, and knowledge attitude and perception of prescribers and dispensers, inadequate medical training, pharmaceutical promotion, lack of rapid and sufficient diagnostic tests, and patient–doctor interaction as major factors among healthcare providers. We further discuss initiatives that, if taken and implemented, can have an impact on and improve the current situation in Europe. MDPI 2018-12-23 2019-01 /pmc/articles/PMC6338985/ /pubmed/30583571 http://dx.doi.org/10.3390/ijerph16010027 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Machowska, Anna
Stålsby Lundborg, Cecilia
Drivers of Irrational Use of Antibiotics in Europe
title Drivers of Irrational Use of Antibiotics in Europe
title_full Drivers of Irrational Use of Antibiotics in Europe
title_fullStr Drivers of Irrational Use of Antibiotics in Europe
title_full_unstemmed Drivers of Irrational Use of Antibiotics in Europe
title_short Drivers of Irrational Use of Antibiotics in Europe
title_sort drivers of irrational use of antibiotics in europe
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338985/
https://www.ncbi.nlm.nih.gov/pubmed/30583571
http://dx.doi.org/10.3390/ijerph16010027
work_keys_str_mv AT machowskaanna driversofirrationaluseofantibioticsineurope
AT stalsbylundborgcecilia driversofirrationaluseofantibioticsineurope